The combination of PD-L1 expression and decreased tumor-infiltrating lymphocytes is associated with a poor prognosis in triple-negative breast cancer

This study included patients with primary triple-negative breast cancer (TNBC) who underwent resection without neoadjuvant chemotherapy between January 2004 and December 2014. Among the 248 TNBCs studied, programmed cell death ligand-1 (PD-L1) expression was detected in 103 (41.5%) tumors, and high...

Descripción completa

Detalles Bibliográficos
Autores principales: Mori, Hitomi, Kubo, Makoto, Yamaguchi, Rin, Nishimura, Reiki, Osako, Tomofumi, Arima, Nobuyuki, Okumura, Yasuhiro, Okido, Masayuki, Yamada, Mai, Kai, Masaya, Kishimoto, Junji, Oda, Yoshinao, Nakamura, Masafumi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5362507/
https://www.ncbi.nlm.nih.gov/pubmed/28107186
http://dx.doi.org/10.18632/oncotarget.14698

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5362507/
https://www.ncbi.nlm.nih.gov/pubmed/28107186
http://dx.doi.org/10.18632/oncotarget.14698

Ejemplares similares